Observatoire des droits humains (anglais seulement)

Ebola Vaccine from GSK Fast-tracked into Clinical Trials

(Version anglaise seulement)

An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into human studies and the company plans to build a stockpile of up to 10,000 doses for emergency deployment, if results are good. The research work is being accelerated with funding from an international consortium, reflecting mounting concern over the worst outbreak of the disease that has killed more than 1,500 people in West Africa. GSK's candidate vaccine, being co-developed with the U.S. National...

Lire l'article complet